Clinical Outcomes of the HIV Protease Inhibitor Nelfinavir with Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer: A Phase 1/2 Trial

Ramesh Rengan, Rosemarie Mick, Daniel A. Pryma, Lilie Leming Lin, John Christodouleas, John P. Plastaras, Charles B. Simone, Anjali K. Gupta, Tracey L. Evans, James P. Stevenson, Corey J. Langer, John Kucharczuk, Joseph Friedberg, Sarah Lam, Dana Patsch, Stephen M. Hahn, Amit Maity

Research output: Contribution to journal › Article › peer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical Outcomes of the HIV Protease Inhibitor Nelfinavir with Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer: A Phase 1/2 Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences